Molecular and anatomic considerations in the pathogenesis of breast cancer

Radiation Oncology Investigations

Volumn 7, Issue 1, 1999, Pages 1-12

  Wazer, David E ^a,b   Band, Vimla ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Immortalization; p53; Retinoblastoma protein

Indexed keywords

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER RISK; CELL IMMORTALIZATION; CELL TYPE; FUNCTIONAL ANATOMY; GENETIC SUSCEPTIBILITY; HETEROZYGOSITY LOSS; LIFESPAN; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; TUMOR SUPPRESSOR GENE; VIRUS ONCOGENE; WART VIRUS;

BREAST; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; EPITHELIUM; FEMALE; GENES, BRCA1; HUMANS; NEOPLASMS, RADIATION-INDUCED; TUMOR CELLS, CULTURED;

EID: 0033034190     PISSN: 10657541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6823(1999)7:1<1::AID-ROI1>3.0.CO;2-I     Document Type: Article

References (63)

1. Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990;250:1233-1238.
2. Hall JM, Lee MK, Newman B, et al. Linkage of early onset familial breast cancer to chromosome 17q21. Science 1990;250:1684-1689.
3. Wooster R, Neuhausen SL, Mangion J, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994;265:2088-2090.
4. Swift M, Reitnauer PJ, Morrell D, Chase CL. Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 1987;316:1289-1294.
5. Land CE, Boice JD, Shore RE, et al. Breast cancer risk from low dose exposures to ionizing radiation: results of parallel analysis of three exposed populations of women. JNCI 1980;65:353-376.
6. Baverstock KF, Papworth D, Vennart J. Risks of radiation at low dose rates. Lancet 1981;1(8217):430-433.
7. Hrubek Z, Boice JD, Monson RR. Breast cancer after multiple chest fluoroscopies: second follow-up of Massachusetts women with tuberculosis. Cancer Res 1989; 49:229-234.
8. Hildreth NG, Shore RE, Dvoretsky PM. The risk of breast cancer after irradiation of the thymus in infancy. N Engl J Med 1989;321:1281-1284.
9. Miller AB, Howe GR, Sherman GJ, et al. Mortality from breast cancer after irradiation during fluoroscopic examination in patients being treated for tuberculosis. N Engl J Med 1989;321:1285-1289.
10. Mattson A, Bengt-Inge R, Hall P, Wilking N, Rutqvist LE. Radiation-induced breast cancer: long-term follow-up of radiation therapy for benign breast disease. JNCI 1993;85:1679-1685.
11. Bhatia S, Robison LL, Oberlin O, Greenberg M, Bunin G, Fossati-Bellani F, Meadows AT. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996;334:745-751.
12. Cox R. Molecular mechanisms of radiation oncogenesis. Int J Radiat Biol 1994;65:57-64.
13. Hart IR, Saini A. Biology of tumour metastasis. Lancet 1992;339:1453-1457.
14. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-767.
15. Stampfer MR, Bartley JC. Induction of transformation and continuous cell lines from normal mammary epithelial cells after exposure to benzo(a)pyrene. Proc Natl Acad Sci USA 1985;82:2394-2398.
16. Wazer DE, Liu X, Chu Q, Band V. Immortalization of distinct human mammary epithelial cell types by human papilloma virus-16 E6 or E7. Proc Natl Acad Sci USA 1995;93:3687-3691.
17. Gao Q, Hauser SH, Liu X, Wazer DE, Madoc-Jones H, Band V. Mutant p53-induced immortalization of primary mammary epithelial cells. Cancer Res 1996;56: 3129-3133.
18. Bartek J, Barkova J, Kyprianou N, Lalani EN, Staskova Z, Shearer M, Chang S, Taylor-Papadimitriou J. Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of human simian virus 40 large tumor antigen with recombinant retrovirus. Proc Natl Acad Sci USA 1991;88:3520-3514.
19. Clark R, Stampfer M, Milley R, O'Rourke E, Walen KH, Kriegler M, Kopplin J, McCormick F. Transformation of human mammary epithelial cells by oncogenic retroviruses. Cancer Res 1988;48:4689-4694.
20. Pierce JH, Arnstein P, DiMarco E, Artrip J, Kraus MH, Lonardo F, DiFiore PP, Aaronson SA. Oncogenic potential of erbB-2 in human mammary epithelial cells. Oncogene 1991;6:1189-1194.
21. Zhai YF, Beittenmiller H, Wang B, Gould MN, Oakley C, Esselman WJ, Welsch CW. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene. Cancer Res 1993;53:2272-2278.
22. Soule HD, Maloney TM, Wolman SR, Peterson WD, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 1990;50:6075-6086.
23. Briand P, Peterson OW, Van Deurs B. A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium. In Vitro Cell Dev Biol 1987;23:181-188.
24. Shay JW, Tomlinson G, Piatyszek MA, Gollahan LS. Spontaneous in vitro immortalization of breast epithelial cells from a patient with Li-Fraumeni syndrome. Mol Cell Biol 1995;15:425-432.
25. Sager R. Resistance of human cells to oncogenic transformation. Cancer Cells 1984;2:487-494.
26. Hammond SL, Ham SG, Stampfer MR. Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract. Proc Natl Acad Sci USA 1984;81:5435-5439.
27. Band V, Sager R. Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc Natl Acad Sci USA 1989;86: 1249-1253.
28. Zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol 1994;186: 131-156.
29. Munger K, Phelps WC, Bubb V, Howley PM, Schlegel R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for the transformation of primary human keratinocytes. J Virol 1989;63:4417-4421.
30. Watanabe S, Kanda T, Yoshiike K. Human papillomavirus type 16 transformation of primary human embryonic fibroblasts requires expression of open reading frames of E6 and E7. J Virol 1989;63:965-969.
31. DiLonardo A, Venuti A, Marcante ML. Human papillomavirus in breast cancer. Breast Cancer Res Treat 1992;21:95-100.
32. Band V, Zajchowski D, Kulesa V, Sager R. Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proc Natl Acad Sci USA 1990;87: 463-467.
33. Band V, Dalal S, Delmolino L, Androphy EJ. Enhanced degradation of p53 protein in HPV-6 and BPV-1 E6 immortalized human mammary epithelial cells. EMBO J 1993;12:1847-1852.
34. Harris CC. Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. JNCI 1996;88:1442-1455.
35. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991;51:6304-6311.
36. Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell 1994;78:539-542.
37. Taylor-Papadimitriou J, Lane EB. In: Neville MC, Daniel CW, editors. The mammary gland: development, regulation, and function. Volume 6. New York: Plenum Press; 1987. p 181-215.
38. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995;81:323-330.
39. Deng G, Lu Y, Zlotnikov G, Thor AD, Smith HS. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 1996;274:2057-2059.
40. Widschwendter M, Berger J, Daxenbichler G, Muller-Holzner E, Widschwendter A, Mayr A, Marth C, Zeimat AG. Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. Cancer Res 1997;57:4158-4161.
41. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985;312:146-151.
42. Palli D, Roselli del Turco M, Simoncini R, Bianchi S. Benign breast disease and breast cancer: a case-control study in a cohort in Italy. Int J Cancer 1991;47:703-706.
43. London SJ, Connolly JL, Schnitt SJ, Colditz GA. A prospective study of benign breast disease and the risk of breast cancer. JAMA 1992;267:941-944.
44. Dupont WD, Parl FF, Hartmann WH, Brinton LA, Winfield AC, Worrell JA, et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 1993;71:1258-1265.
45. Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 1985;55:2698-2708.
46. Page DL. Cancer risk assessment in benign breast biopsies. Hum Pathol 1986;17:871-874.
47. O'Connell P, Pekkel V, Fuqua S, Osborne CK, Allred DC. Molecular genetic studies of early breast cancer evolution. Breast Cancer Res Treat 1994;32:5-12.
48. O'Connell, Pekkel V, Fuqua SAW, Osborne CK, Clark GM, Allred DC. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. JNCI 1998;90:697-703.
49. Berx G, Cleton-Jansen AM, Nollet F, deLeeuvv WJ, Cornelisse C, van Roy F. E-cadherin is a tumor invasion/suppressor gene mutated in human lobular breast cancers. EMBO J 1995;14:6107-6115.
50. Davidoff AM, Humphrey PA, Iglehart JD, Marks JR. Genetic basis for p53 overexpression in human breast cancer. Proc Natl Acad Sci USA 1991;88:5006-5010.
51. Gutmann D, Wood D, Collins F, Identification of the neurofibromatosis type I gene product. Proc Natl Acad Sci USA 1991;88:9658-9662.
52. Friedman LS, Ostermeyer EA, Lynch ED, Szabo CI, Anderson LA, Dowd P, et al. The search for BRCA1. Cancer Res 1994;54:6374-6382.
53. Borek C. X-ray-induced in-vitro neoplastic transformation of human diploid cells. Nature 1980;283:776-778.
54. Namba M, Nishitani F, Hyodoh F, Fukushima F, Kimoto T. Neoplastic transformation of human diploid fibroblasts (KMST-6) by treatment with Co-60 gamma rays. Int J Cancer 1985;35:275-280.
55. Tuynder M, Godfrine S, Cornelis JJ, Rommeleare J. Dose-dependent induction of resistance to terminal differentiation in x-irradiated culture of normal human keratinocytes. Proc Natl Acad Sci USA 1991;88:2638-2642.
56. Dipaolo JA. Relative difficulties in transforming human and animal cells in vitro. JNCI 1983;70:3-8.
57. Kuettel MR, Thraves PJ, Jung M, Varghese S, Prasad S, Rhim J, Dritschilo A. Radiation-induced neoplastic transformation of human prostate epithelial cells. Cancer Res 1996;56:5-10.
58. Wazer DE, Chu Q, Liu X, Gao Q, Safaii H, Band V. Loss of p53 protein during radiation transformation of primary human mammary epithelial cells. Mol Cell Biol 1994;14:2468-2478.
59. Sager R. Tumor suppressor genes: the puzzle and the promise. Science 1989;246:1406-1412.
60. Liu X, Wazer DE, Watanabe K, Band V. Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progres-sion. Cancer Res 1996;56:3371-3379.
61. Riegman P, Klaasen P, van der Korput J, Romijn J, Trapman J. Molecular cloning and characterization of novel prostate antigen cDNAs. Biochem Biophys Res Commun 1988;155:181-188.
62. Wolf DA, Schulz P, Fittler F. Transcriptional regulation of prostate kallikrein-like genes by androgen. Mol Endocrinol 1992;6:753-762.
63. Fukushima D, Kitamura N, Nakanishi S. Nucleotide sequence of cloned cDNA for human pancreatic kallikrein. Biochemistry 1985;24:8037-8043.